Author:
Akinosoglou Karolina,Tsiakalos Aristotelis,Dimopoulou Ioanna D.,Schinas Georgios,Polyzou Eleni,Kourea-Kremastinou Jenny,Pitiriga Vassiliki C.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference19 articles.
1. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757–89.
2. Clegg A, Passey M, Yoannes M, Michael A. High rates of genital mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol. 1997;35:197–200.
3. Jonduo ME, Vallely LM, Wand H, Sweeney EL, Egli-Gany D, Kaldor J, et al. Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum: a systematic review and meta-analysis. BMJ Open. 2022;12:e062990.
4. Waites KB, Bade DJ, Bebear C, Brown SD, Davidson MK, Duffy LB, et al. Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline. CLSI Standards: Guidelines for Health Care Excellence. Wayne (PA); 2011.
5. Zhang W, Li L, Zhang X, Fang H, Chen H, Rong C. Infection prevalence and antibiotic resistance levels in Ureaplasma urealyticum and Mycoplasma hominis in gynecological outpatients of a tertiary hospital in China from 2015 to 2018. Can J Infect Dis Med Microbiol. 2021;2021:8842267.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献